Retatrutide is an experimental metabolic medication designed for significant weight loss and metabolic improvement.
It is a triple agonist, meaning it activates:
GLP-1 receptor
- Reduces appetite
- Slows stomach emptying
- Improves blood sugar control
GIP receptor
- Enhances insulin response
- May improve fat metabolism
- Can reduce nausea compared to GLP-1 alone
Glucagon receptor
- Increases energy expenditure
- Promotes fat burning
- Helps counteract metabolic slowdown during weight loss
Main effects
- Powerful appetite suppression
- Major weight loss
- Improved insulin sensitivity
- Better blood sugar control
- Increased calorie burning
- Reduced liver fat
Potential benefits
- Obesity treatment
- Type 2 diabetes improvement
- Fatty liver disease
- Cardiometabolic risk reduction
Disclaimer: This is for research and informational purposes only. Our products are not for human consumption. For medical advice or diagnosis, consult a professional.
